|
| |
| FRIDAY,
MARCH 23, 2001 |
| 08:30-10:00
|
PLENARY
SESSION IV: PREVENTION OF STROKE
Chairpersons:
M.G. Bousser, France
L. Csiba, Hungary
|
Hall
A |
| 08:30 |
ATRIAL
FIBRILLATION - PRIMARY AND SECONDARY PREVENTION
D.G. Sherman, San Antonio, TX, USA |
|
| 08:45 |
CHOICE
OF ANTIPLATELET DRUGS
J.D. Easton, Providence, RI, USA |
|
| 09:00 |
ANGIOPLASTY
AND STENTING FOR THE PREVENTION OF STROKE
R.D.G. Ferguson, Kingston, Ontario, Canada |
|
| 09:15 |
LIPID
LOWERING IN STROKE PREVENTION
P. Amarenco, Paris, France |
|
| 09:30 |
SYMPTOMATIC
SURGERY - NEW PERSPECTIVES
P.M. Rothwell
Oxford, UK |
|
| 09:45 |
ASYMPTOMATIC
SURGERY - NEW PERSPECTIVES
H.J.M. Barnett, London, Ontario, Canada |
|
| 10:00 |
Coffee
Break and Poster Visit |
|
| 10:30-12:30 |
PLENARY
SESSION V: THE YOUNG STROKE
Chairpersons:
G. Ozdemir, Turkey
R.L. Sacco, USA
|
Hall
A |
| 10:30 |
STROKE
IN YOUNG ADULTS - AN OVERVIEW
J.W. Norris, Toronto, Ontario, Canada |
|
| 10:54 |
THE
YOUNG STROKE : ARTERIAL DISSECTIONS
M-G. Bousser, Paris, France |
|
| 11:18 |
PATENT
FORAMEN OVALE
G. Devuyst, J. Bogousslavsky, Lausanne, Switzerland |
|
| 11:42 |
MIGRAINE
AND STROKE
H-C. Diener, Essen, Germany |
|
| 12:06 |
CEREBRAL
VENOUS THROMBOSIS
M-G. Bousser, Paris, France |
|
| 12:30 |
Lunch
Break |
|
| 14:00-15:30 |
CLINICAL
I
Chairpersons:
G. Devuyst, Switzerland
E. Diez-Tejedor, Spain
|
Hall
A |
| 14:00 |
BLOOD
PRESSURE ALTERATIONS AFTER STROKE IN HYPERTENSIVES AND NORMOTENSIVES
A.D. Efstratopoulos, A. Baltas, S. Sasiakou, S. Voyaki, E. Karabatsaki,
L. Mourgos, M. Meikopoulos, Athens, Greece |
|
| 14:10 |
NOCTURNAL
BLOOD PRESSURE MONITORED BY AMBULATORY BLOOD PRESSURE MONITORING IN
HYPERTENSIVE PATIENTS WITH SUBCORTICAL INFARCTION
W.W. Zhang, Z. Zhang, Beijing, China |
|
| 14:20 |
CHARACTERISTIC
ACTIVITIES AT THE ONSET OF SEVERE BRAIN HEMORRHAGE
Y. Hirata, Akita, Japan |
|
| 14:30 |
CILLIARY
ARTERY STROKE IN CHILDREN
A.M. Chutorian, J. Winterkorn, USA |
|
| 14:40 |
POST-STROKE
DEPRESSION IN A GREEK POPULATION ASSESSED BY A POSTAL-FOLLOW-UP
QUESTIONNAIRE
J. Ellul, N.P. Lekka, G. Gioldasis, A. Stathopoulou, C. Paschalis,
Patras, Greece |
|
| 14:50 |
BETATHROMBOGLOBULIN
AND PLATELET FACTOR-4 AS PLATELET ACTIVATING FACTORS IN ISCHEMIC STROKE,
AND THEIR RELATIONSHIP WITH TYPE OF STROKE, RISK FACTORS AND DISABILITY
T. Tombul, C. Atbas, O. Onlar, O. Tanik, Turkey |
|
|
15:00 |
VASCULAR
VERTIGO IN CHRONIC CHAGAS DISEASE: PICA AND AICA INFARCTIONS
J.L. Cardenas, A. Garcia, B. Certanec, C. Diaz-Salazar, R. Gallardo, C.
Diaz-Horzella, C. Gonzalez, Santiago, Chile |
|
| 15:10 |
ROLE
OF CHANGES IN HEMOSTATIC PARAMETERS IN PATIENTS WITH ACUTE ISCHEMIC
STROKE
S. Mandic-Radic, A. Jovicic, R. Caicevic, V. Subota, Belgrade,
Yugoslavia |
|
| 15:30 |
Coffee
Break and Poster Visit |
|
| 14:00-15:40 |
TREATMENT
AND PREVENTION
Chairpersons:
G.W. Albers, USA
H.C. Diener, Germany
|
Hall
B |
| 14:00 |
THE
MEYER'S SPOT EXERCISE PROGRAM IN THE PREVENTION OF STROKES
G.G. Celesia, A. Perrin Ross, Maywood, IL, USA |
|
| 14:10 |
THE
VALUE OF POTASSIUM AND MAGNESIUM FROM GREEN AND BLACK TEA TO THE STROKE
PREVENTION
P. Jovic, A. Jovicic, R. Raicevic, D. Viljancic, Belgrade, Yugoslavia |
|
| 14:20 |
DECOMPRESSIVE
CRANIECTOMY IN LARGE HEMISPHERIC INFARCTION: LOW MORTALITY RATE BUT NOT
FUNCTIONALLY GOOD OUTCOMES
U. Utku, C. Kilincer, N. Turgut, S. Cobanoglu, A. Gorgulu, Edirne,
Turkey |
|
| 14:30 |
THROMBOEMBOLIC
PROPHYLAXIS IN NON RHEUMATIC ATRIAL FIBRILLATION PATIENTS:
A NORTH ISRAEL SURVEY
M. Blich, S. Honigman, B. Gross, Haifa, Israel |
|
| 14:40 |
ESTIMATING
THE NUMBER OF ACUTE STROKE PATIENTS ELIGIBLE FOR THROMBOLYSIS IN A GREEK
UNIVERSITY NEUROLOGY DEPARTMENT
P. Talelli, G. Gioldasis, J. Ellul, N.P. Lekka, P. Polychronopoulos, S.
Terzis, C. Paschalis, Patras, Greece |
|
| 14:50 |
FEVER
FROM INTRACEREBRAL HEMORRHAGE: THERAPEUTIC EFFECT OF NAPROXEN
A.D. Efstratopoulos, S.M. Voyaki, K. Leuow, H. Lydakis, M. Meikopoulos,
Athens, Greece |
|
| 15:00 |
ANTITHROMBOTIC
TREATMENT IN PATIENTS HOSPITALIZED FOR ATRIAL FIBRILLATION - EFFECT OF
WARFARIN TREATMENT ON TOTAL MORTALITY AND CEREBROVASCULAR EVENTS DURING
2-YEARS FOLLOW-UP
G. Thomassen, M. Hansen, J.B. Hansen, Tromso, Norway |
|
| 15:10 |
TRANSCATHETER
CLOSURE OF PATENT FORAMEN OVALE IN PATIENTS WITH PARADOXICAL EMBOLISM
USING THE STARFLEX® OCCLUSION DEVICE: A SINGLE CENTER EXPERIENCE
P. Vermeersch, M. Vaerenberg, P. Van Den Heuvel, Antwerp, Belgium |
|
| 15:20 |
INTRAARTERIAL
THROMBOLYSIS IN LARGE BRAIN STEM INFARCT PATIENTS
Y. Krespi, O. Minareci, M. Kolukisa, M. Degirmenci, M.E. Gurol, O. Coban,
R. Tuncay, S. Bahar, Istanbul, Turkey |
|
| 15:30 |
NEUROPROTECTIVE
EFFECTS OF SEMAX (ACTH 4-10) IN ACUTE ISCHEMIC STROKE (IS)
V.I. Skvortsova, E.I. Gusev, A.A. Alexeev, N.F. Myasoedov, K.S. Raevsky,
Moscow, Russia |
|
| 15:40 |
Coffee
Break and Poster Visit |
|
| 14:00-15:40 |
EPIDEMIOLOGY
Chairpersons:
H. Markus, UK
S. Meairs, Germany
|
Hall
C |
| 14:00 |
VALIDATION
OF A MODEL FOR ESTIMATING STROKE INCIDENCE IN A POPULATION
B. Schau, R.L. Sacco, B. Boden-Albala, J. Cheng, T. Truelsen, G. Boysen,
C. Zaher, E. Babamoto, M. Deric, G. Davies, Santa
Monica, CA, USA, Denmark, Germany |
|
| 14:10 |
ISTANBUL
STROKE REGISTRY: ANALYSIS OF 1260 CONSECUTIVE PATIENTS
M.E. Gurol, Y. Krespi, B. Tugcu, M. Degirmenci, O. Coban, R. Tuncay, S.
Bahar, Istanbul, Turkey |
|
| 14:20 |
INCIDENCE
AND CAUSES OF STROKE IN PREGNANCY AND PUERPERIUM. PRELIMINARY DATA
S. Congia, M.V. Saddi, A. Cannas, M. Vacca, G. Borghero, M. Mura, M.
Manca, A. Mela, E. Manca, Cagliari, Italy |
|
| 14:30 |
STROKE
OF JAPAN, ITS PAST AND PROSPECT
K. Nakajima, K. Suzuki, Kyoto, Japan |
|
| 14:40 |
THE
FREQUENCY OF ANTIPHOSPHOLIPID ANTIBODIES-CLINICAL CHARACTERISTICS AND
ISCHEMIC BRAIN DISEASE
A. Jovicic, R. Raicevic, D. Djordjevic, B. Magdic, L. Markovic, M.
Jovanovic, Belgrade, Yugoslavia |
|
| 14:50 |
RISK
FACTORS OF ISCHEMIC STROKE IN JORDAN: STUDY OF 100 PATIENTS
M.V. Stoupa-Hadidi, Amman, Jordan |
|
| 15:00 |
PREVALENCE
OF CARDIOVASCULAR RISK FACTORS IN A SPANISH ELDERLY COHORT
F. Bermejo P., A. Martinez-Salio, R. Trincado, D. Munoz, S. Vega, R.
Gabriel, Madrid, Spain |
|
| 15:10 |
ANALYSIS
OF FACTORS INFLUENCING THE SURVIVAL OF ACUTE STROKE PATIENTS: A
MODELLING APPROACH
L. Csiba, L. Kardos, A. Lengyel, J. Szasz, D. Bereckzki, Debrecen,
Hungary, Romania |
|
| 15:20 |
STROKES
IN YOUNG INHABITANTS OF MOSCOW AREA
V. Neretin, I. Vostrikova, S. Kotov, Moscow, Russia |
|
| 15:30 |
Coffee
Break and Poster Visit |
|
| 14:00-15:30 |
EXPERIMENTAL
Chairpersons:
A. Catto, UK
S. Schwab, Germany
|
Hall
D |
| 14:00 |
EXPRESSION
PROFILING IN ACTIVATED AND NON-ACTIVATED MACROPHAGES: EVIDENCE FOR
TARGETED UPREGULATION OF ONCOGENES AND TRANSCRIPTION FACTORS
B. Saint-Jore, F. Koskas, R. Kucherlapati, J. Chapman, J. Thillet,
Paris, France |
|
| 14:10 |
EFFECT
OF TRANS RESVERATROL ON ISCHEMIA REPERFUSION INDUCED BY MIDDLE CEREBRAL
ARTERY OCCLUSION IN RATS
Y.K. Gupta, K. Sinha, G. Chaudhary, New Delhi, India |
|
| 14:20 |
TREATMENT
OF STROKE IN RAT WITH ADULT BONE MARROW STROMAL CELLS
M. Chopp, Y. Li, J. Chen, L.Wang, USA |
|
| 14:30 |
LONG
TERM SUBCORTICAL DAMAGE FOLLOWING TRANSIENT MIDDLE CEREBRAL ARTERY
OCCLUSION IN THE RAT CORRELATES TO CORRESPONDING T2-WEIGHTED MRI LESION
SIZE AND SELECTIVE BEHAVIORAL INDICES
G.C. Palmer, J. Peeling, D. Corbett, M.R. Del Bigio, T.J. Hudzik,
Boston, MA, USA, Canada |
|
| 14:40 |
ASCORBATE
GENERATES OXIDATIVE STRESS IN RAT BRAIN SLICES CAUSING APOPTOSIS:A NEW STROKE MODEL
S.H. Shin, J.H. Song, Kingston, Ontario, Canada |
|
| 14:50 |
ANTI-THROMBIN
THERAPY TO AMELIORATE CIRCULATORY DISTURBANCE AFTER 10 MINUTES OF
FOREBRAIN ISCHEMIA IN THE GERBIL
T. Mima, Y-J. Jin, T. Hirayama, M.G. Mostafa, K. Kori, Kochi, Japan |
|
| 15:00 |
CHANGES
OF MEAN RED BLOOD CELL VELOCITY AND VESSEL DIAMETER BY CEREBRAL ISCHEMIA
AND REPERFUSION IN MALE STROKE-PRONE SPONTANEOUSLY HYPERTENSIVE RATS
(SHRSP)
T. Noguchi, K. Ikeda, Y. Sasaki, J. Yamamoto, J. Seki, Y. Nara, Y.
Yamori, Kyoto, Japan |
|
| 15:10 |
EFFECTS
OF SESAMIN AND VITAMIN E ON HYPERTENSION AND CEREBRAL THROMBOGENESIS IN
STROKE-PRONE SPONTANEOUSLY HYPERTENSIVE RATS (SHRSP)
T. Noguchi, K. Ikeda, Y. Sasaki, J. Yamamoto, J. Seki, H. Hara, H.
Kakuta, Y. Nara, Y. Yamori, Kyoto, Japan |
|
| 15:30 |
ALZHEIMER'S-TYPE
NEURODEGENERATION FOLLOWING ISCHEMIA-REPERFUSION BRAIN INJURY
R. Pluta, Warsaw, Poland |
|
| 15:40 |
Coffee
Break and Poster Visit |
|
| 16:00-18:00 |
BOEHRINGER
INGELHEIM SATELLITE SYMPOSIUM: KEY ISSUES IN EFFECTIVE STROKE CARE -
BENEFITS VERSUS RISKS
Chairpersons:
N.M. Bornstein, Israel
G. Ozdemir, Turkey
|
Hall
A |
| 16:00 |
ASPIRIN
FAILURES - HOW TO MANAGE?
N.M. Bornstein, Israel |
|
| 16:30 |
BENEFITS
AND RISKS OF THERAPY WITH ANTIPLATELETS
H.C. Diener, Germany |
|
| 17:00 |
ASPECTS
OF MANAGEMENT OF ACUTE STROKE
J.D. Easton, USA |
|
| 17:30 |
CRITICAL
ASPECTS OF ANTICOAGULANT THERAPY IN THE PREVENTION OF STROKE
D.G. Sherman, USA |
|
top |
